Can-Fite BioPharma American Depositary Shares
CANF
7 hedge funds and large institutions have $1.84M invested in Can-Fite BioPharma American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
2% less capital invested
Capital invested by funds: $1.87M → $1.84M (-$29.2K)
30% less funds holding
Funds holding: 10 → 7 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$127K |
| 2 |
Morgan Stanley
New York
|
+$42.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$35K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$17K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TAM
1
Taylor Asset Management
Toronto,
Ontario, Canada
| $1M | – | – | – |
|
|
MIH
2
Meitav Investment House
Bene-Beraq,
Israel
| $518K | +$127K | +33 | +27% |
|
|
3
Morgan Stanley
New York
| $284K | +$42.5K | +11 | +17% |
|
|
RJA
4
Raymond James & Associates
St Petersburg,
Florida
| $17K | – | – | – |
|
|
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $10.1K | – | – | – |
|
|
AF
6
Advisornet Financial
Minnetonka,
Minnesota
| $4K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $2K | +$3.86K | +1 | New |
|
|
VF
8
Virtu Financial
New York
| – | -$35K | -9 | Closed |
|
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$17K | -4 | Closed |
|
|
TSS
10
Two Sigma Securities
New York
| – | -$17K | -4 | Closed |
|
|
IA
11
IFP Advisors
Tampa,
Florida
| – | -$3K | -1 | Closed |
|
CANF Hedge Fund Activity: Q4 2018 in Review
7 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q4 2018, worth a combined $1.84M — down 1.6% from $1.87M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CANF and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Meitav Investment House, adding an estimated $127K. The largest seller was Virtu Financial, exiting entirely with an estimated $35K sold.
- 7 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q4 2018, down from 10 in Q3 2018.
- Funds reported $1.84M of Can-Fite BioPharma American Depositary Shares stock for Q4 2018, down 1.6% quarter-over-quarter.
- 1 fund opened new Can-Fite BioPharma American Depositary Shares positions in Q4 2018 and 4 closed out, a net change of -3 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q4 2018 was Meitav Investment House, an estimated $127K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q4 2018 was Virtu Financial, an estimated $35K sold.
Based on aggregated 13F filings for Q4 2018.